-
NEWS
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25Learn MoreThe Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common...
-
NEWS
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and DevelopmentLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries,...
-
BLOG
How AMR impacts vulnerable populationsAction is needed to slow drug-resistant infections in vulnerable populations.Learn More